GlassScriptPhysician profile
Elena Ocher
NPI 1770589335
$7,157.03
in general payments reported to CMS, 2019-2025
39 companies · $633 in 2025
The $633 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,383 · 2020: $474 · 2021: $1,142 · 2022: $1,221 · 2023: $1,368 · 2024: $936 · 2025: $633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,936.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,918.81 | 2021-2025 | |
| Allergan, INC. | $462.70 | 2019-2022 | |
| Pfizer INC. | $353.91 | 2019-2025 | |
| Boston Scientific Corporation | $274.94 | 2019-2022 | |
| Daiichi Sankyo INC. | $271.49 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $247.46 | 2020-2021 | |
| Amgen INC. | $241.85 | 2019-2021 | |
| Nevro Corp. | $239.36 | 2019-2024 | Senza |
| Biohaven Pharmaceutical Holding Company LTD. | $184.26 | 2022 | |
| Almatica Pharma LLC | $164.98 | 2021-2023 | Gralise |
| Axsome Therapeutics, INC. | $160.57 | 2025 | Symbravo |
| Novartis Pharmaceuticals Corporation | $138.98 | 2019 | |
| Lilly USA, LLC | $132.00 | 2019-2024 | Emgality |
| Horizon Therapeutics Plc | $128.35 | 2019-2021 | |
| Lundbeck LLC | $123.07 | 2020-2025 | Vyepti |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elena Ocher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.